Levothyroxine Sodium Tablet
Product Images NDC 51655-783

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 783 52 Rev A 08 21)

Label (51655 783 52   Rev A 08 21)
Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.15 mg) strength. The oral tablet comes in a package of 30 tablets and is prescription only. Labeler is Northwind Health Company, LLC. The label includes storage instructions and cautions to keep out of reach of children and to protect from light and moisture.*
FDA Label Image

Description (Levothyroxine Str)

Description (Levothyroxine Str)
Chemical structure diagram of levothyroxine sodium illustrating iodine-substituted aromatic rings connected through an ether linkage to an amino acid-like structure containing an amine group and a carboxylate sodium salt with associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.